RFD IP Business Services Press Releases

• Published on November 12, 2013 - 04:00 GMT

  VIVUS Qsymia Patents: Challenges Filed to Second Family of European Applications

  Robert Diggs Deeper: Can Vivus overcome the prior disclosure of formulation details in Europe? SAN FRANCISCO, USA, November 11, 2013 /EINPresswire.com/ -- A pair of prior art challenges was filed with the European Patent Office against two Vivus patent …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on October 2, 2013 - 12:38 GMT

  VIVUS Qsymia Patents: Two Vivus Patent Applications Covering Qsymia Allowed by the USPTO

  Robert Diggs Deeper: Assuming the allowed applications issue as patents, Qsymia’s patent term may now extend into 2028 SAN FRANCISCO, USA, October 2, 2013 /EINPresswire.com/ -- As of market close on October 1st, the prosecution status of two pending …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on September 24, 2013 - 13:51 GMT

  VIVUS Qsymia Patents: Vivus and Its Lawyers Acknowledge the Materiality of Weaknesses in the Qsymia Patent Position

  Robert Diggs Deeper: Vivus' patent counsel Mintz Levin makes all RFD patent reports a matter of the official record at the USPTO SAN FRANCISCO, USA, September 24, 2013 /EINPresswire.com/ -- On September 16th, Vivus' patent counsel Mintz Levin …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on August 12, 2013 - 12:45 GMT

  VIVUS Qsymia Patents: Appearance of Ongoing and Systematic Inequitable Conduct before the USPTO

  Robert Diggs Deeper: What Is the Role of Current Vivus Patent Counsel Mintz Levin? SAN FRANCISCO, USA, August 12, 2013 /EINPresswire.com/ -- Earlier today RFD IP Business Services ("RFD") released a new report analyzing the likely inequitable …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on August 11, 2013 - 00:00 GMT

  VIVUS European Qsymia Patent: Third Party Challenge Filed

  Robert Diggs Deeper: Was the Combination of Topiramate and Phentermine Really New When Vivus’ Qsymia Patent Was First Filed? SAN FRANCISCO, USA, August 11, 2013 /EINPresswire.com/ -- Today a prior art challenge against one of Vivus’ pending patent …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on August 9, 2013 - 13:07 GMT

  New Report on VIVUS’ Qsymia Patents: An Intellectual Property House of Cards

  Robert Diggs Deeper: A Comprehensive Analysis of Vivus’ Market Exclusivity on Qsymia® SAN FRANCISCO, USA, August 9, 2013 /EINPresswire.com/ -- RFD IP Business Services ("RFD") yesterday released a hard-hitting report (http://vivuspatent. …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...